<DOC>
	<DOCNO>NCT00036517</DOCNO>
	<brief_summary>The triple combination chemotherapy irinotecan , 5-fluorouracil leucovorin ( CPT-11/5-FU/LV Saltz regimen ) treatment choice patient advance colorectal cancer . Severe diarrhea , unfortunately , side effect treatment . Preclinical study indicate botanical drug PHY906 reduce diarrhea without compromise effectiveness chemotherapy . The primary purpose clinical study evaluate safety , tolerability minimum effective dose PHY906 administer conjunction Saltz regimen .</brief_summary>
	<brief_title>Safety Study Chemotherapy Modulator PHY906 Patients With Advanced Colorectal Cancer</brief_title>
	<detailed_description>CPT-11/5-FU/LV active combination agent treatment colorectal cancer , one dose-limiting toxicity diarrhea . PHY906 show reduce severity CPT-11–induced toxicity without compromise antitumor efficacy vivo animal model . Additionally , long historical experience Far East demonstrate safety PHY906 human . Thus , conduct double-blind , placebo-controlled study evaluate safety tolerability PHY906 . This dose escalation study also examine effect PHY906 ( 1.2 , 2.4 , 3.6 g/day ) pharmacokinetics CPT-11 5-FU concomitant administration CPT-11 , 5-FU , LV , severity CPT-11–induced toxicity diarrhea .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Inclusion Criteria Patients must : 18 75 year age , inclusive , time enrollment . advanced colorectal carcinoma , may either measurable nonmeasurable . receive either CPT11 , FU , cytotoxic chemotherapy agent set ( include adjuvant ) within 1 year prior screen . Eastern Cooperative Oncology Group ( ECOG ) performance status score 0 1. use effective contraceptive method patient reproductive potential enrol study , since potential effect herbs develop fetus unknown . estimate life expectancy least 20 week . provide write informed consent . adequate organ function indicate follow laboratory value ; laboratory value must obtain within 14 day prior study enrollment : Bone marrow reserve : absolute granulocyte count ( AGC ) equal 1.5 X 10 ( power 9 ) /L , platelet count equal 100 X 10 ( power 9 ) /L , hemoglobin level equal 9 g/dL . Hepatic function : serum total bilirubin concentration great 1.5 mg/dL , aspartate transaminase ( AST serum glutamicoxaloacetic transaminase [ SGOT ] ) , alanine transaminase ( ALT serum glutamicpyruvic transaminase [ SGPT ] ) level great grade 2 toxicity determine NCICTC version 2.0 . Renal function : serum creatinine level great grade 2 toxicity determine CTC version 2.0 . Exclusion Criteria Patients : Gilbert syndrome ( familial , nonhemolytic , acholuric jaundice ) . patient enterostomy . untreated brain metastasis deteriorate neurological function completion cranial irradiation . woman currently pregnant and/or breastfeeding . active infection serious systemic disorder , opinion principal investigator , incompatible study product and/or procedure . use investigational agent within 4 week study entry . know hypersensitivity study medication , excipients , analog , component herb .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2004</verification_date>
	<keyword>Stage III Stage IV colorectal cancer</keyword>
	<keyword>diarrhea</keyword>
	<keyword>reduce</keyword>
	<keyword>alleviate</keyword>
	<keyword>modulate</keyword>
	<keyword>Saltz regimen</keyword>
	<keyword>CPT-11</keyword>
	<keyword>irinotecan</keyword>
	<keyword>camptosar</keyword>
	<keyword>5-fluorouracil</keyword>
	<keyword>leucovorin</keyword>
	<keyword>5-FU</keyword>
	<keyword>LV</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>side effect</keyword>
	<keyword>toxicity</keyword>
	<keyword>botanical drug</keyword>
	<keyword>herbal medicine</keyword>
	<keyword>chinese herbal medicine</keyword>
	<keyword>traditional chinese medicine</keyword>
	<keyword>TCM</keyword>
	<keyword>oral dose</keyword>
	<keyword>oral administration</keyword>
	<keyword>concomitant use</keyword>
</DOC>